Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
34 studies found for:    "cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy" OR "Cerebral Arterial Diseases"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed Normal Values of Brain Oxygenation
Condition: Cerebral Arterial Disease
Intervention:
2 Completed Quantifying Collateral Perfusion in Cerebrovascular Disease-Moyamoya Disease and Stroke Patients
Conditions: Cerebrovascular Accident;   Moyamoya Disease
Intervention: Drug: Xenon as contrast agent
3 Not yet recruiting Superiority of Rt-PA + Tenecteplase in Comparison With Rt-PA Only in Proximal Middle Cerebral Artery Occlusion
Conditions: Nervous System Disorders;   Cerebral Artery
Interventions: Drug: rt-PA;   Drug: tenecteplase
4 Unknown  Study of Purified Umbilical Cord Blood CD34+ Stem Cell on Chronic Ischemic Stroke
Conditions: Ischemic Stroke;   Ischaemic Cerebral Infarction;   Infarction, Middle Cerebral Artery;   Ischemia;   Brain Ischemia
Intervention: Procedure: Intercerebral implantation of allogenic CD34+ stem cell
5 Terminated The Efficacy and Safety of MK0724 IV for Improvement of Neurological Damage and Recovery From Middle Cerebral Artery Ischemic Stroke (0724-018)
Condition: Middle Cerebral Artery Stroke
Interventions: Drug: Comparator: Placebo;   Drug: Comparator: MK0724
6 Recruiting Subclavian Vein catheterization_Seldinger Vs Modified Seldinger
Conditions: Brain Neoplasm;   Intracranial Aneurysm;   Cerebrovascular Moyamoya Disease
Interventions: Procedure: Seldinger technique;   Procedure: Modified Seldinger technique
7 Recruiting Autologous Bone Marrow Stromal Cell and Endothelial Progenitor Cell Transplantation in Ischemic Stroke
Conditions: Stroke;   Infarction, Middle Cerebral Artery
Interventions: Genetic: Autologous BMSCs transplantation;   Genetic: Autologous EPCs transplantation;   Genetic: IV infusion of placebo
8 Withdrawn F-18-AV-45 Uptake, Spot Sign Presence and Cerebral Amyloid Angiopathy (CAA) in Primary Intracranial Hemorrhage (ICH)
Condition: Cerebral Amyloid Angiopathy
Intervention:
9 Completed Gait Training for Persons With Stroke
Conditions: Stroke;   Middle Cerebral Artery Infarction
Interventions: Behavioral: Lokomat  - Physical therapy;   Behavioral: Physical therapy - Lokomat
10 Recruiting Study Evaluating the Safety,Tolerability and Efficacy of PF-04360365 in Adults With Probable Cerebral Amyloid Angiopathy
Condition: Cerebral Amyloid Angiopathy
Interventions: Biological: Ponezumab;   Other: placebo
11 Terminated Decompressive Craniectomy In Malignant Middle Cerebral Artery Infarcts
Condition: Malignant Middle Cerebral Artery Infarction
Interventions: Procedure: Decompressive hemicraniectomy and duraplasty;   Procedure: hemicraniectomy
12 Recruiting Moyamoya Disease Biomarkers in Patients With Intracranial Atherosclerotic Stroke
Conditions: Moyamoya Disease;   Intracranial Atherosclerotic Stroke;   Intracranial Steno-occlusive Disease
Intervention:
13 Terminated A Study to Evaluate the Efficacy and Safety of Piracetam on Aphasia After Acute Ischemic Cerebral Artery Stroke
Condition: Acute Ischaemic Middle Cerebral Artery Stroke
Interventions: Drug: Piracetam;   Other: Placebo
14 Not yet recruiting Methods of Etiological Diagnosis of Cerebral Amyloid Angiopathy
Conditions: Cerebral Amyloid Angiopathy;   Intracerebral Hemorrhage
Intervention:
15 Enrolling by invitation Generation of a Cellular Model of CADASIL From Skin Fibroblasts
Condition: CADASIL
Intervention: Other: Skin biopsy
16 Completed Efficacy Study of CD34 Stem Cell in Chronic Stroke Patients
Conditions: Stroke;   Middle Cerebral Artery Infarction
Interventions: Procedure: Intercerebral implantation of Autulogous Stem Cells;   Drug: convention therapy
17 Completed Multicenter Efficacy Study of Recombinant Human Erythropoietin in Acute Ischemic Stroke
Conditions: Infarction, Middle Cerebral Artery;   Middle Cerebral Artery Stroke;   Stroke, Acute
Interventions: Drug: recombinant human erythropoietin alfa;   Drug: 0.9% NaCl
18 Completed Autologous Bone Marrow Stem Cells in Middle Cerebral Artery Acute Stroke Treatment.
Conditions: Stroke, Acute;   Infarction, Middle Cerebral Artery
Intervention: Procedure: Infusion on autologous CD34+ stem cells into middle cerebral artery
19 Unknown  Autologous Bone Marrow Stem Cells in Ischemic Stroke.
Conditions: Stroke, Acute;   Infarction, Middle Cerebral Artery
Intervention: Procedure: Infusion of autologous CD34+ stem cells into middle cerebral artery
20 Completed Impact of Cranioplasty On Cerebral Perfusion
Conditions: Head Injuries;   Subarachnoid Haemorrhage;   Intra-cerebral Haemorrhage;   Cerebral Thrombosis;   Infarction, Middle Cerebral Artery
Intervention: Procedure: Cerebral perfusion evaluation

   Previous Page Studies Shown (1-20) Next Page (21-34) Show next page of results    Last Page
Indicates status has not been verified in more than two years